Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | DS-1062a |
Trade Name | |
Synonyms | |
Drug Descriptions |
DS-1062a is an antibody-drug conjugate comprising an antibody that targets TROP2 linked to the topoisomerase I inhibitor DXd, which may inhibit tumor growth (J Clin Oncol 36, 2018 (suppl; abstr e24206)). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C151967 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DS-1062a | DS-1062a | 0 | 3 |
DS-1062a + Durvalumab | DS-1062a Durvalumab | 0 | 1 |
DS-1062a + Pembrolizumab | DS-1062a Pembrolizumab | 0 | 1 |